sito/Files seminari...del 1qter/ dup 3qter Since beginning of 90’s, it was known that...

46
Genomic variation and disease Genomic variation and disease Array-CGH - 5 years in Brazil 2004-2009 5 year USP 5 year USP

Transcript of sito/Files seminari...del 1qter/ dup 3qter Since beginning of 90’s, it was known that...

Genomic variation and diseaseGenomic variation and disease

Array-CGH - 5 years in Brazil

2004-2009

5 year USP5 year USP

Genomic variation and diseaseGenomic variation and disease

Cytogenetics in 2000

� ~ half of patients with MR had no diagnosis – No precise risk of recurrence

– No carrier detection

– No prenatal diagnosis

5 year USP5 year USP

del 1qter / dup 3qter

Since beginning of 90’s, it was known that submicroscopic alterations

accounted for some of the MR (Flint/ subtelomeres)

Genomic variation and diseaseGenomic variation and disease

� FISH – high-resolution but limited number the sequences per time

� How to investigate a large number of target simultaneously:

– Array-CGH conceived by Pinkel and published by Lichter.

5 year USP

Genomic variation and diseaseGenomic variation and disease

Array-CGH – 2000Array-based Comparative Genomic

Hybridization

Markers (DNA sequences ordered on the chromosomes)

1 Mb

5 year USP5 year USP

Normal

amplified

deleted

Detect and measure intensities

deleção

Reference DNA

Test DNA

Array hybridization

cot1

Superposed images

Test DNA Reference DNA

•3500 BACs at ~1 Mb distribution

in the genome

Gráfico das intensidades (teste/referência) de cada

sonda ordenadas no genoma

1p Yq

Log2 verde/verm

elho

sondas

5 year USP5 year USP

Genomic variation and diseaseGenomic variation and disease

Projeto “Doelmatigheid” (“cust benefit”)

� 2002-2003

� Project at LUMC– “Improved prevention of mental retardation by the use of genome micro-array analysis as a complementary tool to chromosome diagnosis”.

� Built up array CGH.

� Investigation of idiophatic mental retardation.

5 year USP5 year USP

Genomic variation and diseaseGenomic variation and disease

Genomic arrays:

� 3500 BACs/PACs: – Markers spaced at ~ 1 Mb whole genome.

– Subtelomeric probes (Flint)

� Set of probes from the Sanger Center (based on the human genome sequence)– BAC-end sequences verified

– Only 20% probes FISH verified

– Constantly verified by users (freely distributed among academic institutions)

5 year USP5 year USP

Genomic variation and diseaseGenomic variation and disease

Protocols: Workshop Sanger Center

� Workshop 2002 (Welcome Trust):– Carter et al:Cytometry 2002;49(2):43-48

� Publication:– Fiegler et al:Genes Chromosomes Cancer2003;36(4):361-74

– New protocols used about 10% of the DNA used in previous arrays and obtained much better quality.

5 year USP5 year USP

Genomic variation and diseaseGenomic variation and disease

Array Production (LUMC)

� Grow 3500 Bacterias

� Isolate 3.500 BAC DNAs

� BAC DNA amplification:– = ~ 20.000 PCRs

5 year USP5 year USP

1 Mb arrays: Tested in cell lines

-2.1

-1.8

-1.5

-1.2

-0.9

-0.6

-0.3

0

0.3

0.6

0.9

1.2

1.5

1.8

2.1

21170 21370 21570 21770 21970 22170 22370 22570 22770

Cromossomo 11

Amer. J. Med. Genet, in press

Genomic variation and diseaseGenomic variation and disease

3.5 Mb amplification

Unique position number Clone name Chromosome Mb position

29230 RP11-219A15 17 16528821

29240 RP11-524F11 17 17340469

29250 RP11-189D22 17 17942724

29260 RP1-162E17 17 19090463

29270 CTB-1187M2 17 19175621

29280 RP11-78O7 17 19577928

29290 RP5-836L9 17 19977261

29300 RP11-121A13 17 20075917

Amplification on 17p

5 year USP5 year USP

http://www.ensembl.org/Homo_sapiens/cytoview?chr=17&vc_start=16286331&vc_end=21286331

Amplified clones

Genomic variation and diseaseGenomic variation and disease

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

1.1

1.2

22240 22440 22640 22840 23040 23240

q31.1-qterq12.3-q32.1

q12.3-q33.2q?-q12.3

pter-q?

5 year USP5 year USP

Genomic variation and diseaseGenomic variation and disease

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

1.1

1.2

22240 22440 22640 22840 23040 23240

5 year USP5 year USP

Genomic variation and diseaseGenomic variation and disease

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

1.1

1.2

22240 22440 22640 22840 23040 23240

5 year USP5 year USP

pter-q?

-2.1

-1.8

-1.5

-1.2

-0.9

-0.6

-0.3

0

0.3

0.6

0.9

1.2

1.5

1.8

2.1

24610 24810 25010 25210 25410 25610

q31.1-qterq12.3-q32.1

Secondary deletion

A

B

C

Primary deletion

Genomic variation and diseaseGenomic variation and disease

Brazil – 2004_2008

� Arrays produced in Leiden.

� Genetic counseling at University of São Paulo– Service started >40 years ago.

– Insufficiente to provide genetic counseling to all in need.

– It has no financing

– Faculties see patients connected to their own projects using research money

� i.e., craniofacial anomalies, obesity, XLMR, etc.

5 year USP5 year USP

Genomic variation and diseaseGenomic variation and disease

Brazil – 2004_2008

� Arrays produced in Leiden were provided free of charge.

� ~ 400 families with unexplained MR and⁄or congenital abnormalities.

5 year USP5 year USP

Submicroscopic chromosome imbalances in 16% of the patients (de novo or

inherited from a balanced parent)

Genomic variation and diseaseGenomic variation and disease

28% idiophatic

craniosynostosis showed

submicroscopic

chromosome alterations.

Carrier mother

5 year USP5 year USP

Genomic variation and diseaseGenomic variation and disease

16% MR.

~ 30% if ascertained by a criteria other

than MR.

Frequency of submicroscopic chromosome alterations

� ~ 16 among patients ascertained because of MR

� But up to 30% if patients ascertained by a criteria other than MR.

5 year USP5 year USP

DECIPHER

17q21.31 deletion = ~ 0.7% of all mental retardation

Genomic variation and diseaseGenomic variation and disease

Copy number variation associated to specific syndromes

Genomic variation and diseaseGenomic variation and disease

But...

Many CNVs not obviously associated to anything

Large scale variation of DNA segments(50 kb – 2 Mb) em larga escala.

Inherited alterations

Genomic variation and diseaseGenomic variation and disease

Inherited alterations

5 year USP5 year USP

Genomic variation and diseaseGenomic variation and disease

-29% of patients (4/14)

5 year USP5 year USP

5 year USP5 year USP

Mb

B

Oligo-array image

0

+1

-1

15 16 17 18 19 20 Mb

Clin Dysmorphol. 2008 Jan;17(1):13-7.

LinksExpanding the phenotype of 22q11 deletion syndrome: the MURCS association.

Uliana V, Giordano N, Caselli R, Papa FT, Ariani F, Marcocci C, Gianetti E, Martini G, Papakostas P, Rollo F, Meloni I, Mari F, Priolo M, Renieri A, Nuti R.

Genomic variation and diseaseGenomic variation and disease

After 2006

� 1 Mb arrays: “low-resolution”

� BAC tile-path arrays lower quality.

� Production BAC arrays expansive and labour intensive.

� Use of comercial oligo-arrays.

5 year USP5 year USP

Genomic variation and diseaseGenomic variation and disease

a

dc

b

Genomic variation and diseaseGenomic variation and disease

Chromosome 17 profiles of the 3 patients as seen in SignalMap – ARRAY 244K

USP00002173

USP00002203

USP00002009

DGV track

Probe log 2 ratios plotted along y-axis

Deletion on 17p

Genomic variation and diseaseGenomic variation and disease

•Confirmado por FISH

•De novo em todos os casos

Genomic variation and diseaseGenomic variation and disease

congenital miasteny

syndrome

Genomic variation and diseaseGenomic variation and disease

Which array platform?

� Agilent platform?

5 year USP5 year USP

Genomic variation and diseaseGenomic variation and disease5 year USP5 year USP

Genomic variation and diseaseGenomic variation and disease

Frequency of alterations with increased resolution

� Submicroscopic copy number imbalances is associated to 15-30% of unexplained MR and congenital abnormalities.

� This frequency does not seem to vary a lot between 3500 BAC arrays, 35000 BAC arrays or 44.000 oligos.

5 year USP5 year USP

Genomic variation and diseaseGenomic variation and disease

Diagnosis – Which size alterations should we look at?

� Larger alterations are more likely to cause a phenotype.

� Larger alterations are less likely to be inherited from normal parents.

� Alterations below certain size (400Kb? 250Kb?) are not investigated – cost/benefit.

5 year USP5 year USP

Genomic variation and diseaseGenomic variation and disease

� Geneticistas Clínicos– Fernando Kok

– Paulo Otto

Angela M. Vianna-Morgante

Ana C. Krepischi-Santos

� Colaboradores:

� Rafaella M.P. Nascimento

� Regina C. Mingroni-Netto

� Maria Rita Passos-Bueno

� Celia Koiffmann

5 year USP5 year USP